Pr. Sandra Lassalle

Pr. Sandra Lassalle

Pathologist

Pr. Sandra Lassalle is a specialist in anatomical and cytopathology, a medical discipline dedicated to the microscopic analysis of tissue and tumor samples. This work enables the establishment of a diagnosis and the identification of key prognostic factors, helping to guide therapeutic decisions. She is recognized as a national authority and a European expert in ophthalmic pathology.

Short Bio

Professor Sandra Lassalle has been a pathologist at the Nice University Hospital since 2003. She is the hospital’s lead ophthalmic pathologist in France and one of the European specialists in the field, analyzing all tissue samples from patients operated on in the ophthalmology department at the Nice University Hospital. She established a dedicated ophthalmopathology collection within the Nice University Hospital biobank ([BB-0033-0025] (https://biobank-cotedazur.fr/)) to support national and international research teams in advancing the understanding of ocular cancer mechanisms and identifying therapeutic targets that may eventually improve patient care.

Professor Lassalle is also involved in ophthalmology-focused research projects within the team led by Corine Bertolotto and Robert Ballotti, specializing in uveal melanoma at the Mediterranean Center for Molecular Medicine.

Additionally, she serves as a Professor at the Faculty of Medicine in Nice, where she teaches anatomical pathology to medical students at various levels.

Career path

  • Medical internship (1997-2003) at the University of Nice Sophia-Antipolis, Nice
  • University Hospital Assistant in Anatomy-Pathology (2003-2007) at the Nice University Hospital, Nice
  • Assistant Professor – Full-time Hospital Practitioner (2007-2024), Clinical and Experimental Pathology Laboratory (LPCE), Biology-Pathology Division at Nice University Hospital
  • Full Professor – Full-time Hospital Practitioner (2024-present), Clinical and Experimental Pathology Laboratory (LPCE), Biology-Pathology Division at Nice University Hospital

Education

  • Master’s Degree in Biological and Medical Sciences (2003) – University of Nice Sophia-Antipolis, Nice, France
  • Specialized Studies Diploma (DES) in Anatomical and Cytopathology (2003) – University of Aix-Marseille II, Marseille, France
  • State Diploma of Doctor of Medicine (2003) – University of Nice Sophia-Antipolis, Nice, France
  • Master of Advanced Studies in Pharmacology and Cellular & Molecular Biology (DEA, 2004) – University of Nice Sophia-Antipolis, Nice, France
  • PhD in Life and Health Sciences (2010) – University of Nice Sophia-Antipolis, Nice, France
  • Interuniversity Diploma (DIU) in Molecular Pathology (2013) – University of Nice Sophia-Antipolis, Nice, France
  • University Diploma (DU) in Legal Compensation for Bodily Injury (2016) – University of Nice Sophia-Antipolis, Nice, France
  • Accreditation to Supervise Research (HDR) (2022) – Université Côte d'Azur, Nice, France

Publications

Publications: 75
Citations: 1,034 by 884 publications
h-index: 19
ORCID: https://orcid.org/0000-0003-1692-2440

  • Nahon-Estève S, Orbach D, Le Loarer F, Hofman P, Lassalle S. Fibroblastic orbital tumour with NTRK1 fusion transcript: when TRK inhibitors rescue surgery. Can J Ophthalmol. 2024;59(4):e407-e409. doi: 10.1016/j.jcjo.2023.11.008
  • Mudhar HS, Krishna Y, Cross S, Auw-Haedrich C, Barnhill R, Cherepanoff S, Eagle R, Farmer J, Folberg R, Grossniklaus H, Herwig-Carl MC, Hyrcza M, Lassalle S, Loeffler KU, Moulin A, Milman T, Verdijk RM, Heegaard S, Coupland SE. A Multicenter Study Validates the WHO 2022 Classification for Conjunctival Melanocytic Intraepithelial Lesions With Clinical and Prognostic Relevance. Lab Invest. 2024;104(1):100281. doi: 10.1016/j.labinv.2023.100281
  • Lamas NJ, Lassalle S, Martel A, Nahon-Estève S, Macocco A, Zahaf K, Lalvee S, Fayada J, Lespinet-Fabre V, Bordone O, Pedeutour F, Baillif S, Hofman P. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort. Pathology. 2023;55(7):929-944. doi: 10.1016/j.pathol.2023.08.003
  • Nahon-Estève S, Martel A, Maschi C, Baillif S, Lassalle S, Caujolle JP. Swept-Source and Spectral-Domain OCT Imaging of Conjunctival Tumors. Ophthalmology. 2021;128(6):947-950. doi: 10.1016/j.ophtha.2020.09.036
  • Lassalle S, Nahon-Esteve S, Frouin E, Boulagnon-Rombi C, Josselin N, Cassoux N, Barnhill R, Scheller B, Baillif S, Hofman P. PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome. Int J Mol Sci. 2020;21(23):9147. doi:10.3390/ijms21239147

Publication list